AmeriCann, Inc (ACAN) Fair Value & Analysis
Real Estate · US · Market cap $2.4K
AmeriCann, Inc
ACAN · US
Fair value as of: Jun 26, 2026
From 1 valuation models · updated 3 days ago
Fair value updated Jun 26, 2026 — revised from $0.8200 to $0.0002 (−100.0%) since Jun 24, 2026.
Price vs Fair Value (12 months)
12‑month range $0.0002 – $0.0020 · the $0.0002 price screens below the $0.0002 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
AmeriCann, Inc (ACAN) currently trades at $0.0002, while our model-based Fair Value estimate is $0.0002 — implying the stock looks roughly 0.0% undervalued today. We read business quality at 92/100 (high quality), in the Real Estate sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Trailing-twelve-month revenue stands at $799K. Revenue declined 64.5% year over year. It earns a return on equity of -54.8%. Net debt stands at $9.2M. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
AmeriCann, Inc. designs, develops, leases, and operates cannabis cultivation, processing, and manufacturing facilities in the United States. The company's flagship project is the Massachusetts Cannabis Center that is developed on a 52.6 -acre parcel of undeveloped land located in Freetown, Massachusetts. It also provides medical cannabis and adult-use cannabis. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. The company was incorporated in 2010 and is headquartered in Denver, Colorado.
Revenue & earnings trend
FY2020 – FY2024 · reported fiscal years
AmeriCann, Inc reported revenue of $1.3M in FY2024 versus $504K in FY2020, a compound +26.1%/yr. Reported net income was −$1.3M in FY2024.
Open the full interactive analysis →
Similar stocks
6 more Real Estate Services stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Vingroup Joint Stock Company VIC | 219,800 VND | 33,299 VND | -85% |
| CBRE Group CBRE | $129.95 | $78.11 | -40% |
| Plaza S.A MALLPLAZA | 3,800 CLP | 5,905 CLP | +55% |
| SAGAB SAGAB | kr 148.00 | kr 174.10 | +18% |
| SAGAA SAGAA | kr 147.00 | kr 108.52 | -26% |
| SAGAD SAGAD | kr 33.15 | kr 26.52 | -20% |
Explore undervalued stocks
More undervalued Real Estate stocks →
Frequently asked questions
Is AmeriCann, Inc (ACAN) undervalued?
What is the fair value of ACAN?
What is the quality score of ACAN?
What is the revenue of AmeriCann, Inc (ACAN)?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.